• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染性心内膜炎 30 天后再入院:来自全国再入院数据库的分析。

Thirty-Day Readmission After Infective Endocarditis: Analysis From a Nationwide Readmission Database.

机构信息

1 Cardiovascular Center Tazuke Kofukai Foundation Medical Research Institute Kitano Hospital Osaka Japan.

出版信息

J Am Heart Assoc. 2019 May 7;8(9):e011598. doi: 10.1161/JAHA.118.011598.

DOI:10.1161/JAHA.118.011598
PMID:31020901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6512130/
Abstract

Background The contemporary incidence of and reasons for early readmission after infective endocarditis ( IE ) are not well known. Therefore, we analyzed 30-day readmission demographics after IE from the US Nationwide Readmission Database. Methods and Results We examined the 2010 to 2014 Nationwide Readmission Database to identify index admissions for a primary diagnosis of IE with survival at discharge. Incidence, reasons, and independent predictors of 30-day unplanned readmissions were analyzed. In total, 11 217 patients (24.8%) were nonelectively readmitted within 30 days among the 45 214 index admissions discharged after IE . The most common causes of readmission were IE (20.5%), sepsis (8.7%), complications of device/graft (8.1%), and congestive heart failure (7.6%). In-hospital mortality and the valvular surgery rates during the readmissions were 8.1% and 9.1%, respectively. Discharge to home or self-care, undergoing valvular surgery, aged ≥60 years, and having private insurance were independently associated with lower rates of 30-day readmission. Length of stay of ≥10 days, congestive heart failure, diabetes mellitus, renal failure, chronic pulmonary disease, peripheral artery disease, and depression were associated with higher risk. The total hospital costs of readmission were $48.7 million per year (median, $11 267; interquartile range, $6021-$25 073), which accounted for 38.6% of the total episodes of care (index+readmission). Conclusions Almost 1 in 4 patients was readmitted within 30 days of admission for IE . The most common reasons were IE , other infectious causes, and cardiac causes. A multidisciplinary approach to determine the surgical indications and close monitoring are necessary to improve outcomes and reduce complications in in-hospital and postdischarge settings.

摘要

背景 目前,感染性心内膜炎(IE)患者的早期再入院率及其原因尚不清楚。因此,我们分析了美国全国再入院数据库中 30 天再入院的患者情况。

方法和结果 我们调查了 2010 年至 2014 年的全国再入院数据库,以确定原发性 IE 诊断患者的索引入院,并记录其出院时的存活情况。分析了 30 天内非计划性再入院的发生率、原因和独立预测因素。在 45214 例 IE 出院的索引入院中,共有 11217 例(24.8%)在 30 天内非计划性再入院。再入院的最常见原因是 IE(20.5%)、败血症(8.7%)、器械/移植物并发症(8.1%)和充血性心力衰竭(7.6%)。再入院的院内死亡率和瓣膜手术率分别为 8.1%和 9.1%。出院至家庭或自我护理、接受瓣膜手术、年龄≥60 岁和拥有私人保险与较低的 30 天再入院率独立相关。住院时间≥10 天、充血性心力衰竭、糖尿病、肾衰竭、慢性肺部疾病、外周动脉疾病和抑郁症与较高的再入院风险相关。每年再入院的总住院费用为 4870 万美元(中位数为 11267 美元;四分位距为 6021 美元-25073 美元),占总治疗次数(索引+再入院)的 38.6%。

结论 近 1/4 的 IE 患者在入院后 30 天内再次入院。最常见的原因是 IE、其他感染性原因和心脏原因。需要采取多学科方法来确定手术适应证,并密切监测,以改善住院和出院后的结局并减少并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7af6/6512130/6adfd9f00cd7/JAH3-8-e011598-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7af6/6512130/6adfd9f00cd7/JAH3-8-e011598-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7af6/6512130/6adfd9f00cd7/JAH3-8-e011598-g001.jpg

相似文献

1
Thirty-Day Readmission After Infective Endocarditis: Analysis From a Nationwide Readmission Database.感染性心内膜炎 30 天后再入院:来自全国再入院数据库的分析。
J Am Heart Assoc. 2019 May 7;8(9):e011598. doi: 10.1161/JAHA.118.011598.
2
Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study.感染性心内膜炎患者 30 天再入院的预测因素:一项全国基于人群的队列研究。
Rev Cardiovasc Med. 2020 Mar 30;21(1):123-127. doi: 10.31083/j.rcm.2020.01.552.
3
Comparison of 30-day readmission rates and risk factors between carotid artery stenting and endarterectomy.颈动脉支架置入术与动脉内膜切除术的30天再入院率及危险因素比较。
J Vasc Surg. 2017 Nov;66(5):1432-1444.e7. doi: 10.1016/j.jvs.2017.05.097. Epub 2017 Aug 31.
4
Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?哪些临床和患者因素会影响全关节置换术后再入院的国家经济负担?
Clin Orthop Relat Res. 2017 Dec;475(12):2926-2937. doi: 10.1007/s11999-017-5244-6.
5
Six-month readmissions after bariatric surgery: Results of a nationwide analysis.减重手术后 6 个月的再入院率:一项全国性分析的结果。
Surgery. 2019 Nov;166(5):926-933. doi: 10.1016/j.surg.2019.06.003. Epub 2019 Aug 6.
6
Outcomes and Resource Utilization Associated With Readmissions After Atrial Fibrillation Hospitalizations.房颤住院患者再入院的结局和资源利用情况。
J Am Heart Assoc. 2019 Oct;8(19):e013026. doi: 10.1161/JAHA.119.013026. Epub 2019 Sep 19.
7
Causes, Risk Factors, and Costs of 30-Day Readmissions After Mitral Valve Repair and Replacement.二尖瓣修复和置换术后 30 天再入院的原因、危险因素和费用。
Ann Thorac Surg. 2019 Dec;108(6):1729-1737. doi: 10.1016/j.athoracsur.2019.07.033. Epub 2019 Aug 31.
8
Thirty-Day Readmission Rates, Timing, Causes, and Costs after ST-Segment-Elevation Myocardial Infarction in the United States: A National Readmission Database Analysis 2010-2014.美国 ST 段抬高型心肌梗死患者 30 天再入院率、时间、原因和费用:2010-2014 年全国再入院数据库分析。
J Am Heart Assoc. 2018 Sep 18;7(18):e009863. doi: 10.1161/JAHA.118.009863.
9
National Landscape of Unplanned 30-Day Readmission Rates for Acute Non-hemorrhagic Diverticulitis: Insight from National Readmission Database.急性非出血性憩室炎 30 天再入院率的国家景观:来自国家再入院数据库的见解。
Dig Dis Sci. 2021 Apr;66(4):1009-1021. doi: 10.1007/s10620-020-06284-5. Epub 2020 May 1.
10
Incidence, predictors, causes, and costs of 30-day readmission after in-hospital cardiopulmonary resuscitation in the United States.美国院内心肺复苏后 30 天再入院的发生率、预测因素、原因和费用。
Resuscitation. 2019 Jan;134:19-25. doi: 10.1016/j.resuscitation.2018.12.001. Epub 2018 Dec 16.

引用本文的文献

1
Outcomes after bioprosthetic versus mechanical mitral valve replacement for infective endocarditis in the United States.美国生物瓣与机械瓣置换治疗感染性心内膜炎的疗效比较。
JTCVS Open. 2023 Dec 3;17:74-83. doi: 10.1016/j.xjon.2023.11.019. eCollection 2024 Feb.
2
Trends in Infective Endocarditis Mortality in the United States: 1999 to 2020: A Cause for Alarm.美国感染性心内膜炎死亡率趋势:1999 年至 2020 年:敲响警钟。
J Am Heart Assoc. 2023 Dec 19;12(24):e031589. doi: 10.1161/JAHA.123.031589. Epub 2023 Dec 13.
3
Human Serum Supplementation Promotes Streptococcus mitis Growth and Induces Specific Transcriptomic Responses.

本文引用的文献

1
Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data: The AHRQ Elixhauser Comorbidity Index.利用医院管理数据识别再入院和住院死亡率增加的风险:AHRQ埃利克斯豪泽共病指数
Med Care. 2017 Jul;55(7):698-705. doi: 10.1097/MLR.0000000000000735.
2
Trends in Infective Endocarditis in California and New York State, 1998-2013.1998 - 2013年加利福尼亚州和纽约州感染性心内膜炎的发病趋势
JAMA. 2017 Apr 25;317(16):1652-1660. doi: 10.1001/jama.2017.4287.
3
High readmission rates and mental distress after infective endocarditis - Results from the national population-based CopenHeart IE survey.
人血清补充促进缓症链球菌生长并诱导特定的转录组反应。
Microbiol Spectr. 2023 Jun 15;11(3):e0512922. doi: 10.1128/spectrum.05129-22. Epub 2023 Apr 4.
4
Differences in Sex and the Incidence and In-Hospital Mortality among People Admitted for Infective Endocarditis in Spain, 2016-2020.2016 - 2020年西班牙感染性心内膜炎住院患者的性别差异、发病率及院内死亡率
J Clin Med. 2022 Nov 20;11(22):6847. doi: 10.3390/jcm11226847.
5
Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage.注射吸毒者中的严重细菌感染:注射相关组织损伤的作用。
Harm Reduct J. 2022 May 2;19(1):41. doi: 10.1186/s12954-022-00624-6.
6
Pulmonary complications observed in patients with infective endocarditis with and without injection drug use: An analysis of the National Inpatient Sample.患有和不患有注射吸毒的感染性心内膜炎患者的肺部并发症:国家住院患者样本分析。
PLoS One. 2021 Sep 3;16(9):e0256757. doi: 10.1371/journal.pone.0256757. eCollection 2021.
7
Short- and long-term outcomes of infective endocarditis admission in adults: A population-based registry study in Finland.成人感染性心内膜炎住院的短期和长期结局:芬兰基于人群的登记研究。
PLoS One. 2021 Jul 15;16(7):e0254553. doi: 10.1371/journal.pone.0254553. eCollection 2021.
8
Infective endocarditis and solid organ transplantation: Only worse outcomes during initial transplantation hospitalization.感染性心内膜炎与实体器官移植:初始移植住院期间结局更差。
Am Heart J. 2021 Oct;240:63-72. doi: 10.1016/j.ahj.2021.06.007. Epub 2021 Jun 20.
9
Insight into the epidemiology of infective endocarditis in Portugal: a contemporary nationwide study from 2010 to 2018.洞察葡萄牙感染性心内膜炎的流行病学:一项2010年至2018年的当代全国性研究。
BMC Cardiovasc Disord. 2021 Mar 16;21(1):138. doi: 10.1186/s12872-021-01937-3.
10
A Contemporary Population-Based Profile of Infective Endocarditis Using the Expanded Rochester Epidemiology Project.利用扩展的罗切斯特流行病学项目对感染性心内膜炎进行的当代基于人群的概况分析。
Mayo Clin Proc. 2021 Jun;96(6):1438-1445. doi: 10.1016/j.mayocp.2020.08.044. Epub 2021 Mar 5.
感染性心内膜炎后的高再入院率和精神困扰——基于全国人群的哥本哈根心脏感染性心内膜炎调查结果
Int J Cardiol. 2017 May 15;235:133-140. doi: 10.1016/j.ijcard.2017.02.077. Epub 2017 Feb 24.
4
Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure.老年医疗保险心力衰竭住院患者30天全因再入院与长期预后的关联
Am J Med. 2016 Nov;129(11):1178-1184. doi: 10.1016/j.amjmed.2016.06.018. Epub 2016 Jul 9.
5
Validated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis.用于预测感染性心内膜炎6个月死亡率的验证风险评分
J Am Heart Assoc. 2016 Apr 18;5(4):e003016. doi: 10.1161/JAHA.115.003016.
6
Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011.美国 2000 年至 2011 年感染性心内膜炎发病率、微生物学和瓣膜置换的趋势。
J Am Coll Cardiol. 2015 May 19;65(19):2070-6. doi: 10.1016/j.jacc.2015.03.518.
7
Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis.感染性心内膜炎手术适应证、手术风险与临床结局的相关性:国际心内膜炎协作研究的一项前瞻性研究。
Circulation. 2015 Jan 13;131(2):131-40. doi: 10.1161/CIRCULATIONAHA.114.012461. Epub 2014 Dec 5.
8
Long-term clinical outcome of major adverse cardiac events in survivors of infective endocarditis: a nationwide population-based study.感染性心内膜炎幸存者主要不良心脏事件的长期临床结局:一项全国范围内基于人群的研究。
Circulation. 2014 Nov 4;130(19):1684-91. doi: 10.1161/CIRCULATIONAHA.114.012717. Epub 2014 Sep 15.
9
Infective endocarditis epidemiology over five decades: a systematic review.五十余年来感染性心内膜炎的流行病学:系统综述。
PLoS One. 2013 Dec 9;8(12):e82665. doi: 10.1371/journal.pone.0082665. eCollection 2013.
10
Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis - Prospective Cohort Study.复发性心内膜炎:基于国际心内膜炎前瞻性队列研究的危险因素分析。
Clin Microbiol Infect. 2014 Jun;20(6):566-75. doi: 10.1111/1469-0691.12395. Epub 2013 Nov 11.